European Commission, Directorate-General for Research & Innovation, Directorate Industrial Technologies, Belgium.
J Control Release. 2012 Jul 20;161(2):409-15. doi: 10.1016/j.jconrel.2012.01.044. Epub 2012 Feb 4.
This paper presents an overview of drug delivery research activities funded by the European Union's Seventh Framework Programme for Research and Technological Development (FP7). It gives a brief introduction of the main policies, structure and budget of FP7 with the four Specific Programmes 'Cooperation', 'People', 'Ideas' and 'Capacities' including the ten priority themes of the Specific Programme Cooperation. The priority themes HEALTH, 'Information and Communication Technologies' (ICT) and 'Nanosciences and nanotechnologies, multifunctional Materials and Production technologies' (NMP) and the 'Innovative Medicines Initiative' (IMI) are discussed since they are the main sources of funding for medical and pharmaceutical research. Further details are provided on drug delivery research, notably the funding for development of drug delivery technologies by the NMP priority theme in the context of its funding of nanomedicine research projects. The link is made to the rapidly developing field of biomaterials research for implants and regenerative medicine. The paper highlights the strategic importance of the Key Emerging Technologies (KETs) including nanotechnology for the competitiveness of the medical and pharmaceutical sectors. Finally, there is an outlook to the future Framework Programme for Research 'Horizon 2020'.
本文概述了欧盟第七研发框架计划（FP7）资助的药物输送研究活动。本文简要介绍了 FP7 的主要政策、结构和预算，以及包括合作、人、理念和能力四个具体计划，以及合作具体计划的十个优先主题。本文讨论了优先主题 HEALTH、“信息和通信技术”（ICT）以及“纳米科学和纳米技术、多功能材料和生产技术”（NMP）和“创新药物倡议”（IMI），因为它们是医疗和制药研究的主要资金来源。进一步提供了药物输送研究的详细信息，特别是在其资助纳米医学研究项目的背景下，NMP 优先主题为药物输送技术的发展提供了资金。本文还将这一领域与植入物和再生医学领域快速发展的生物材料研究联系起来。本文强调了包括纳米技术在内的关键新兴技术（KETs）对于医疗和制药部门竞争力的战略重要性。最后，展望了未来的研究框架计划“地平线 2020”。
